You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsDetails

內地疫情刺激新冠藥物板塊造好 三葉草(02197.HK)急漲20%

阿思達克 11-24 15:36
內地疫情持續升溫,A股新冠藥物板塊升2.7%。本港新冠疫苗股也普遍跑贏大市,尤其是三葉草生物-B(02197.HK)連吐三天守穩10天線(4.4元),今天股價重拾升勢,最多飆24%高見5.5元,現報5.31元,急漲20%,成交急增至9,555萬股,涉資4.85億元。 康希諾(06185.HK)、歌禮-B(01672.HK)、復星醫藥(02196.HK)、開拓藥業-B(09939.HK)及騰盛博藥-B(02137.HK)升約2%-4%,後兩者最強曾分別高見12.92元及8.3元,現報12.42元及8.1元,回升3.5%-4.1%。